(P322) Unmet Needs with Current Basal Insulin Therapy: Insights from US Healthcare Professionals

A survey was developed to identify and better understand unmet needs with current basal insulin therapies and gauge the factors contributing to therapeutic inertia around initiating insulin in the United States. A six-question survey was completed by medical liaisons when meeting with 177 US healthcare professionals (HCPs; primary care or endocrinology). HCPs perceived adherence concerns, injection burden, and hypoglycemia as the top unmet needs in current basal insulins; the key driver for delaying insulin initiation was patient preference for a non-injectable agent. HCPs identified once-weekly insulin as a valuable consideration for decreasing injection burden while improving adherence.